Impact of COPD on long-term outcome after ST-segment elevation myocardial infarction receiving primary percutaneous coronary intervention

Chest

Volumn 144, Issue 3, 2013, Pages 750-757

  Campo, Gianluca ^a,b   Guastaroba, Paolo ^c   Marzocchi, Antonio ^d   Santarelli, Andrea ^e   Varani, Elisabetta ^f   Vignali, Luigi ^g   Sangiorgio, Pietro ^g   Tondi, Stefano ^h   Serenelli, Carlotta ⁱ   De Palma, Rossana ^c   Saia, Francesco ^d  

^a Azienda Ospedaliero Universitaria SAnna   (Italy)

^b LTTA Center   (Italy)

^c Area Rischio Infettivo   (Italy)

^d UNIVERSITY OF BOLOGNA   (Italy)

^e OSPEDALE DEGLI INFERMI   (Italy)

^f SANTA MARIA DELLE CROCI HOSPITAL   (Italy)

^g MAGGIORE HOSPITAL   (Italy)

^h Ospedale di Baggiovara   (Italy)

ⁱ Asl Pavia   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CARDIOVASCULAR AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CLOPIDOGREL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRINOGEN RECEPTOR ANTAGONIST; HEPARIN; HIRULOG; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; STEROID; THEOPHYLLINE; TICLOPIDINE;

AGED; ARTICLE; BLEEDING; CHRONIC OBSTRUCTIVE LUNG DISEASE; DISEASE REGISTRY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HIGH RISK PATIENT; HOSPITAL READMISSION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PRACTICE GUIDELINE; PREDICTION; PRIORITY JOURNAL; RECURRENT DISEASE; RISK FACTOR; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

EID: 84884340526     PISSN: 00123692     EISSN: 19313543     Source Type: Journal    
DOI: 10.1378/chest.12-2313     Document Type: Article

References (13)

1. Boyle AH, Waters HF. COPD: focus on prevention: recommendations of the National Lung Health Education Program. Chronic obstructive pulmonary disease. Heart Lung. 2000 ; 29 (6): 446-449.
2. Salisbury AC, Reid KJ, Spertus JA. Impact of chronic obstructive pulmonary disease on post-myocardial infarction outcomes. Am J Cardiol. 2007 ; 99 (5): 636-641.
3. Rusinaru D, Saaidi I, Godard S, Mahjoub H, Battle C, Tribouilloy C. Impact of chronic obstructive pulmonary disease on long-term outcome of patients hospitalized for heart failure. Am J Cardiol. 2008 ; 101 (3): 353-358.
4. Samuels LE, Kaufman MS, Morris RJ, Promisloff R, Brockman SK. Coronary artery bypass grafting in patients with COPD. Chest. 1998 ; 113 (4): 878-882.
5. Han MK, McLaughlin VV, Criner GJ, Martinez FJ. Pulmonary diseases and the heart. Circulation. 2007 ; 116 (25): 2992-3005.
6. Behar S, Panosh A, Reicher-Reiss H, Zion M, Schlesinger Z, Goldbourt U; SPRINT Study Group. Prevalence and prognosis of chronic obstructive pulmonary disease among 5,839 consecutive patients with acute myocardial infarction. Am J Med. 1992 ; 93 (6): 637-641.
7. Wakabayashi K, Gonzalez MA, Delhaye C, et al. Impact of chronic obstructive pulmonary disease on acute-phase outcome of myocardial infarction. Am J Cardiol. 2010 ; 106 (3): 305-309.
8. Campo G, Saia F, Percoco G, et al. Long-term outcome after drug eluting stenting in patients with ST-segment elevation myocardial infarction: data from the REAL registry. Int J Cardiol. 2010 ; 140 (2): 154-160.
9. Marzocchi A, Saia F, Piovaccari G, et al. Long-term safety and effi cacy of drug-eluting stents: two-year results of the REAL (REgistro AngiopLastiche dell'Emilia Romagna) multicenter registry. Circulation. 2007 ; 115 (25): 3181-3188.
10. Campo G, Saia F, Guastaroba P, et al. Prognostic impact of hospital readmissions after primary percutaneous coronary intervention. Arch Intern Med. 2011 ; 171 (21): 1948-1949.
11. Ducrocq G, Wallace JS, Baron G, et al ; REACH Investigators. Risk score to predict serious bleeding in stable outpatients with or at risk of atherothrombosis. Eur Heart J. 2010 ; 31 (10): 1257-1265.
12. Stefan MS, Bannuru RR, Lessard D, Gore JM, Lindenauer PK, Goldberg RJ. The impact of COPD on management and outcomes of patients hospitalized with acute myocardial infarction: a 10-year retrospective observational study. Chest. 2012 ; 141 (6): 1441-1448.
13. Enriquez JR, Parikh SV, Selzer F, et al. Increased adverse events after percutaneous coronary intervention in patients with COPD: insights from the National Heart, Lung, and Blood Institute dynamic registry. Chest. 2011; 140(3): 604-610.